Quantcast

Latest Healthcare in India Stories

2010-11-11 13:20:00

ATLANTA, Nov. 11, 2010 /PRNewswire/ -- Arbor Pharmaceuticals, a specialty pharmaceutical company based in Atlanta, GA, announced today the completion of a $34.8 million financing. This financing included a $17.5 million investment in the form of Series B Preferred Stock led by Signet Healthcare Partners, LLC. The remainder of the financing was in the form of a term loan provided by several of the investing parties. Also participating in both the Series B equity investment and the loan...

2010-11-05 00:00:39

Helping pharma brands build trust with women highlights a session led by The Vue Group's CEO, Sharon Callahan at the 2nd Annual M2W®"“HCâ“ž¢ - The Marketing Pharma & Healthcare to Women Conference, November 16 & 17, Chicago Cultural Center. Callahan will be joined by over 30 pharma and healthcare marketing to women experts speaking at M2W®"“HCâ“ž¢. Chicago, IL (PRWEB) November 4, 2010 "It's not news that...

2010-10-25 05:27:00

NEW DELHI, October 25, 2010 /PRNewswire/ -- - Experts Say Universal Access to Preventive and Curative Intervention is Crucial Health experts participating at a roundtable organised by India Health Progress(IHP) on economic and social impact of non-communicable diseases in India are of the opinion that a concerted effort is required to address the growing burden. A review of variety of papers assessing the burden of non-communicable diseases in India has just been released...

2010-10-04 07:00:00

REDWOOD CITY, Calif., Oct. 4 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. announced today that James H. Welch has joined the company as Chief Financial Officer. "We are very fortunate to continue to attract seasoned leaders in the pharmaceutical industry," stated Richard King, AcelRx President and CEO. "Jim brings over two decades' experience in financial and operational management at life science and high technology firms. His addition to the AcelRx team positions us well for future...

2010-10-04 06:30:00

CALGARY, Oct. 4 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and Chief Executive Officer of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the 9th Annual BIO Investor Forum on Wednesday, October 6th, 2010 at 8:00 a.m. PDT. The conference takes place on October 5th and 6th at the Palace Hotel in San Francisco, CA. A live audio link to the webcast presentation is available at:...

2010-09-27 06:30:00

CALGARY, Sept. 27 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and Chief Executive Officer of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the 5th annual JMP Securities Healthcare Conference on Tuesday, September 28th, 2010 at 10:00 a.m. EDT. The conference takes place from September 27th to 28th at the New York Palace Hotel in New York, NY. A live audio link to the webcast presentation is available at:...

2010-09-22 18:00:00

SINGAPORE, Sept. 23 /PRNewswire/ -- S*BIO Pte Ltd today announced a US$5 million investment by Mitsui Ventures that will support the continued development of S*BIO's clinical programs. "Mitsui Ventures' financing commitment reflects the international investment community's strong interest in our track record in advancing multiple assets through clinical development and the quality of our various preclinical and clinical programs," said Dr. Jan-Anders Karlsson, CEO of S*BIO. "The...

2010-09-15 10:00:00

SAN DIEGO, Sept. 15 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) candidates for the treatment of cancer, respiratory and inflammatory diseases, announced today that it has been named to the annual FierceBiotech "Fierce 15" list, designating it as one of the top and most promising biotech companies in the industry. Every year, FierceBiotech evaluates hundreds of private companies, which is based...

2010-09-09 06:30:00

CALGARY, Sept. 9 /PRNewswire-FirstCall/ - Mr. Doug Ball, Chief Financial Officer of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, September 14th, 2010 at 10:25 a.m. EDT. The conference takes place from September 12th to 15th at the New York Palace Hotel in New York, NY. A live audio link to the webcast presentation is available at:...

2010-09-07 18:00:00

SAN DIEGO, Sept. 7 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences: Morgan Stanley Global Healthcare -- Conference Date: Tuesday, September 14, 2010 Time:...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related